Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli

Am J Pathol. 2004 Aug;165(2):659-69. doi: 10.1016/s0002-9440(10)63330-5.

Abstract

Distinct subpopulations of fibroblasts contribute to lung fibrosis, although the mechanisms underlying fibrogenesis in these subpopulations are not clear. Differential expression of the glycophosphatidylinositol-linked protein Thy-1 affects proliferation and myofibroblast differentiation. Lung fibroblast populations selected on the basis of Thy-1 expression by cell sorting were examined for responses to fibrogenic stimuli. Thy-1 (-) and Thy-1 (+) fibroblast populations were treated with platelet-derived growth factor-BB, interleukin-1beta, interleukin-4, or bleomycin and assessed for activation of transforming growth factor (TGF)-beta, Smad3 phosphorylation, and alpha-smooth muscle actin and fibronectin expression. Thy-1 (-) fibroblasts responded to these stimuli with increased TGF-beta activity, Smad3 phosphorylation, and expression of alpha-smooth muscle actin and fibronectin, whereas Thy-1 (+) fibroblasts resisted stimulation. The unresponsiveness of Thy-1 (+) cells is not because of defective TGF-beta signaling because both subsets respond to exogenous active TGF-beta. Rather, Thy-1 (-) fibroblasts activate latent TGF-beta in response to fibrogenic stimuli, whereas Thy-1 (+) cells fail to do so. Defective activation is common to multiple mechanisms of TGF-beta activation, including thrombospondin 1, matrix metalloproteinase, or plasmin. Thy-1 (-) lung fibroblasts transfected with Thy-1 also become resistant to fibrogenic stimulation, indicating that Thy-1 is a critical biological response modifier that protects against fibrotic progression by controlling TGF-beta activation. These studies provide a molecular basis for understanding the differential roles of fibroblast subpopulations in fibrotic lung disease through control of latent TGF-beta activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Animals
  • Anticoagulants / pharmacology
  • Antineoplastic Agents / pharmacology
  • Becaplermin
  • Bleomycin / pharmacology
  • Cells, Cultured
  • DNA-Binding Proteins / metabolism
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibronectins / metabolism
  • Gene Expression Regulation*
  • Interleukin-1 / pharmacology
  • Interleukin-4 / pharmacology
  • Lung / drug effects
  • Lung / metabolism*
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / metabolism
  • Phosphorylation / drug effects
  • Platelet-Derived Growth Factor / pharmacology
  • Proto-Oncogene Proteins c-sis
  • Pulmonary Fibrosis / metabolism*
  • Pulmonary Fibrosis / pathology
  • Rats
  • Rats, Inbred Lew
  • Recombinant Proteins / pharmacology
  • Signal Transduction
  • Smad3 Protein
  • Thy-1 Antigens / metabolism*
  • Trans-Activators / metabolism
  • Transforming Growth Factor beta / metabolism*

Substances

  • Actins
  • Anticoagulants
  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Fibronectins
  • Interleukin-1
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Recombinant Proteins
  • Smad3 Protein
  • Smad3 protein, rat
  • Thy-1 Antigens
  • Trans-Activators
  • Transforming Growth Factor beta
  • Bleomycin
  • Becaplermin
  • Interleukin-4